Literature DB >> 9858010

Sinus histiocytosis with massive lymphadenopathy involving the orbit: reversal of compressive optic neuropathy after chemotherapy.

S Goldberg1, P Mahadevia, M Lipton, P S Rosenbaum.   

Abstract

A 38-year-old woman from Antigua had compressive optic neuropathy of the right eye caused by orbital involvement with sinus histiocytosis. There was also nasal sinus involvement and massive cervical lymphadenopathy resulting in radiographic compression of the airway and carotid sheath. Because of the compressive optic neuropathy and threat to the airway and carotid perfusion, the patient underwent a 6-month chemotherapeutic regimen of cyclophosphamide, vincristine, and prednisone. After chemotherapy, the visual dysfunction resolved in correlation with diminution of the orbital mass, and marked regression of the cervical lymphadenopathy. This case demonstrates the potential efficacy of chemotherapy in the treatment of compressive optic neuropathy in cases of orbital sinus histiocytosis with massive lymphadenopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9858010

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  4 in total

1.  Rosai-Dorfman disease. Extranodal sinus histiocytosis in three co-existing sites. A case report.

Authors:  Misha Pless; Brian M Chang
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Rosai Dorfman disease or sinus histiocytosis with massive lymphadenopathy of the orbit.

Authors:  R Khan; P Moriarty; S Kennedy
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

3.  Rosai dorfman disease of the orbit.

Authors:  Geeta K Vemuganti; Milind N Naik; Santosh G Honavar
Journal:  J Hematol Oncol       Date:  2008-06-28       Impact factor: 17.388

4.  Isolated Intracranial Rosai-Dorfman Disease.

Authors:  Md Taufiq; Abul Khair; Ferdousy Begum; Shabnam Akhter; Md Shamim Farooq; Mohammed Kamal
Journal:  Case Rep Neurol Med       Date:  2016-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.